As rare disease trials face persistent feasibility challenges, Bayesian designs are gaining momentum by enabling more ...

Marty Makary was appointed commissioner of the Food and Drug Administration (FDA) in 2025. The prominent surgeon, medical researcher, bestselling author, and critic of the medical ...

Scientists have turned to advanced AI to decode the intricate ecosystem of gut bacteria and their chemical signals. Using a Bayesian neural network called VBayesMM, researchers can now identify ...

However, traditional clinical trial designs are often ill-suited for rare disease research with common challenges including ...

Empirical Bayes is a versatile approach to “learn from a lot” in two ways: first, from a large number of variables and, second, from a potentially large amount of prior information, for example, ...